13 Comments

Dr. Mercola Interview with the psychiatrist responsible for ending lobotomies: https://z3news.com/w/the-little-known-sordid-history-of-psychiatry/

Expand full comment

Mercola Interview with the vaxx injured woman from Robert F. Kennedy Jr’s organization: https://www.bitchute.com/video/Npxld717Uxd2/

Expand full comment

At the supermarket, I had to get help from the alcohol lady (since they lock up the expensive liquor in the local supermarket) and when she approached, she was looking for the alcohol and I approached, pointing at what I wanted.

She asked for me to keep my distance. I just had to laugh...(obviously I wasn't wearing a mask, though it be the law)

Then, when she retrieved it, she did the lean head as far back as possible and extend arm as far as she could to hand it to me.

Weird scared people. I pity them. I can smell the fear.

Expand full comment

😂

Expand full comment

"Go sell crazy somewhere else, we're full up here..." Excellent Jack reference...

Expand full comment

"Liberals are bad" mugs wouldn't be bad... ;-)

Expand full comment

We’ll see what we can do. 😁

Expand full comment

Patriot dirt you say? I'll buy your whole stock!

Expand full comment

Niiiice!

Expand full comment

https://trialsitenews.com/feds-coming-after-doctors-pharmacies-that-market-ivermectin-as-effective-safe-for-covid-19/

Feds Coming After Doctors & Pharmacies that Market Ivermectin as Effective & Safe for COVID-19

TrialSite Staff December 24, 2021

The U.S. Food and Drug Administration (FDA) is coming for any physician or pharmacy that promotes ivermectin as a drug that can “prevent Coronavirus Disease 2019,” or COVID-19. Recently, America’s drug regulatory agency claims they received complaints that the antiparasitic drug off-label can treat the novel coronavirus at the same dose used for authorized treatments, writes FDA Acting Branch Chief Branch Shannon Glueck, PharmD. This letter was sent to Humayun J. Chaudhry, DO, MS, FACP, FACOI, President and Chief Executive Officer Federation of State Medical Boards.

As a signal that the FDA will start enforcing actions against individuals and groups positioning or making claims that ivermectin is an effective treatment for COVID-19, the letter calls out that “the FDA has neither authorized nor approved any ivermectin drug product for use in preventing or treating COVID-19. Although clinical trials assessing ivermectin tablets for the prevention or treatment of COVID-19 in people are ongoing, currently available data do not show that ivermectin is safe or effective for the prevention or treatment of COVID-19.”

Referring to some of its previous announcements, declaring the drug a risk for side effects, the FDA cautions the board involved with representing the 71 state medical and osteopathic boards in America and its territories, as well as co-sponsors of the United States Medical Licensing Examination.

Declaring that the drug is not authorized or approved or proven as “safe or effective” for COVID-19, the federal regulator also sent this warning letter to the National Association of Boards of Pharmacy to help “Facilitate communications among associations with shared goals regarding these matters.”

This effort suggests an escalated effort by the regulatory agency to identify, investigate, and potentially punish groups, whether they be physicians or pharmacies, involved with making any marketing claims associated with ivermectin and COVID-19.

TrialSite’s Sonia Elijah reported how the FDA appeared directly involved in a proactive social marketing smear campaign of the drug, seeking to ensure that the human antiparasitic version of the drug would be conflated with the animal variety as well as a general overall blanket warning of possible harm.

Ivermectin traditionally has a stellar safety record when it is applied at the authorized dose and indication. Although a total of 71 studies involving ivermectin have demonstrated for the most part positive data points, a handful of studies that the U.S. federal government focused on failed to show efficacy results. Many of the studies demonstrating success have been completely ignored for a variety of reasons. Generally, the study data from low-and middle-income countries (LMICs) is trusted less than larger randomized controlled studies in America, the UK, or Europe, for example.

Physicians and pharmacies should never directly market that the drug is an approved or effective treatment for COVID-19. Do so at your own risk as the FDA has now put licensing boards on notice.

Expand full comment

Insanity! The FDA is completely captured.

Expand full comment

Ha! "Omicron Hysteria," the new album by CIS White Alpha, available at your favorite retailers!

Expand full comment